Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Three Years On Clomipramine: Before and After Brain SPECT Study

Three Years On Clomipramine: Before and After Brain SPECT Study A case is presented of a patient diagnosed with attention deficit disorder, obsessive thinking, anger outbursts, and depression who had a SPECT study prior to treatment and after 3 years of treatment on clomipramine. The follow-up SPECT study showed marked improvement overall in the cerebral perfusion of the brain. At rest marked overactivity was noted in the anterior medial aspects of the frontal lobes, along with “patchy” (increased and decreased) uptake throughout the cortical and subcortical areas of the brain. After treatment for 3 years on clomipramine at 225 mg a day, the follow-up SPECT study revealed a normalization of activity in the anterior medial aspects of the frontal lobes as well as no patchy uptake cortically and subcortically as noted in the study prior to treatment. The clinical usefulness of the SPECT study as it relates to this case is discussed. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Annals of Clinical Psychiatry Springer Journals

Three Years On Clomipramine: Before and After Brain SPECT Study

Amen, Daniel; Waugh, Martin
Annals of Clinical Psychiatry , Volume 9 (2) – Sep 18, 2004
Download PDF
4 pages

Loading next page...
 
/lp/springer-journals/three-years-on-clomipramine-before-and-after-brain-spect-study-CYiaNvu0Kb
Publisher
Springer Journals
Copyright
Copyright © 1997 by American Academy of Clinical Psychiatrists
Subject
Medicine & Public Health; Neurology; Psychiatry; Psychopharmacology
ISSN
1040-1237
eISSN
1573-3238
DOI
10.1023/A:1026213621022
Publisher site
See Article on Publisher Site

Abstract

A case is presented of a patient diagnosed with attention deficit disorder, obsessive thinking, anger outbursts, and depression who had a SPECT study prior to treatment and after 3 years of treatment on clomipramine. The follow-up SPECT study showed marked improvement overall in the cerebral perfusion of the brain. At rest marked overactivity was noted in the anterior medial aspects of the frontal lobes, along with “patchy” (increased and decreased) uptake throughout the cortical and subcortical areas of the brain. After treatment for 3 years on clomipramine at 225 mg a day, the follow-up SPECT study revealed a normalization of activity in the anterior medial aspects of the frontal lobes as well as no patchy uptake cortically and subcortically as noted in the study prior to treatment. The clinical usefulness of the SPECT study as it relates to this case is discussed.

Journal

Annals of Clinical Psychiatry – Springer Journals

Published: Sep 18, 2004

References

  • Clinical SPECT Imaging
    Devous, MD
  • Focal cerebral hypoperfusion in children with dysphasia and/or attention deficit disorder
    Lou, HC; Henriksen, L; Bruhn, P
  • Effects of fluoxetine on regional cerebral blood flow in obsessive-compulsive patients
    Hoehn-Saric, R; Pearlson, MB; Gordon, HJ
  • Brain SPECT findings and aggressiveness
    Amen, DG; Stubblefield, M; Carmichael, B; Thisted, R
  • Tricyclic antidepressant and methylphenidate treatment of attention deficit disorder in children
    Garfinkel, BD; Wender, PH; Sloman, L
  • Cerebral glucose metabolic rates in non-depressed patients with obsessive compulsive disorder
    Baxter, LR; Schwartz, JM; Mazziotta, JC
  • PET imaging in obsessive-compulsive disorder with and without depression
    Baxter, LR; Schwartz, JM; Guze, BH; Bergman, K; Szuba, MP
  • Elevated medial-frontal cerebral blood flow in obsessive-compulsive patients: A SPECT study
    Machlin, SR; Gordon, HJ; Pearlson, MB
  • Cerebral glucose metabolic rates in obsessive-compulsive disorder
    Nordahl, TE; Benkelfat, C; Semple, WE
  • Cerebral glucose metabolism in childhood onset obsessive-compulsive disorder
    Swedo, SE; Schapiro, MB; Grady, CL
  • Pediatric Neurology: Behavior and Cognition of the Child with Brain Dysfunction
    Kinsbourne, M
  • Treatment of ADHD with fluoxetine: A preliminary trial
    Barrickman, L; Noyes, R; Kuperman, S
  • Generalized Epilepsy
    Mirsky, AF; Duncan, CC
  • Aggression in human correlates with cerebrospinal fluid amine metabolites
    Brown, GL; Goodwin, FK; Ballenger, JC